Brimonidine Tartrate Ophthalmic Solution Solution/ Drops
Product Images NDC 70756-679

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate Ophthalmic Solution (NDC 70756-679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (3b8042bb 0691 4159 8787 Cba97a9e3c5a 01)

FDA Label Image

5 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 02)

5 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 02)
This is a medication label with information about Brimonidine, an ophthalmic solution used for eye treatment. The usual dosage is one drop three times daily to the affected eye(s). The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The solution is manufactured by Lifestar Pharma LLC in the USA and is sterile for eye use only. The label indicates that the bottle is filled to half capacity. The product is a 0.1% solution and is produced in Spain.*
FDA Label Image

Carton 5 mL (3b8042bb 0691 4159 8787 Cba97a9e3c5a 03)

FDA Label Image

10ml Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 04)

10ml Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 04)
This description includes information about a medication with the NDC code 70756-678-30, which is a solution containing Brimonidine Tartrate for ophthalmic use. The usual dosage is one drop three times daily to be applied to the affected eye(s). The product should be stored at 20°C to 25°C (68°F to 77°F) and should be kept at controlled room temperature. The product is manufactured for Lifestar Pharma LLC and is a 0.1% solution. The product is a product of Spain with a specific lot number. Overall, this text provides details about how to use and store the medication.*
FDA Label Image

10 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 05)

FDA Label Image

15 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 06)

15 mL Label (3b8042bb 0691 4159 8787 Cba97a9e3c5a 06)
This is a description of an ophthalmic solution containing Brimonidine Tartrate for use in the eyes. The solution is sterile and is recommended for use three times a day in the affected eye(s). It contains Brimonidine Tartrate USP 0.1% as an active ingredient and a preservative called Stabilized oxychloro complex 0.005%. The product is manufactured by Lifestar Pharma LLC in Mahwah, NJ, USA. Storage instructions indicate keeping the solution at room temperature, between 20°C to 25°C.*
FDA Label Image

15 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 07)

15 mL Carton (3b8042bb 0691 4159 8787 Cba97a9e3c5a 07)
This appears to be a description of an ophthalmic solution called Brimonidine Tartrate for eye use. The product is stored at room temperature and is for single-use only. The solution is used to treat eye conditions and comes in an easy-to-use packaging. It includes detailed instructions on dosage and storage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.